SCHEMBL752725

SCHEMBL752725

Cc1c(F)cc(I)cc1F

nearest known ligand 0.39

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
TTR P02766 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24136102 0.86 TTR (0.43) HDAC1HDAC6TTR
SCHEMBL24699771 0.86 TTR (0.32) HDAC1HDAC6TTR
SCHEMBL21765350 0.82
SCHEMBL21765278 0.82 TTR (0.40) HDAC1HDAC6TTR
SCHEMBL21760181 0.78 HDAC1 (0.31) HDAC1HDAC6
SCHEMBL21756946 0.78 ALDH1A1 (0.32)
SCHEMBL21765351 0.77 TRPV4 (0.36) TTR
SCHEMBL26088361 0.75 KDM4E (0.41) HDAC1HDAC6
SCHEMBL30004335 0.75 KDM4E (0.41) HDAC1HDAC6
SCHEMBL17733622 0.75 TTR (0.32) TTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 93 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260042715-A1 FLUORINATION PROCESS ROYAL COLLEGE OF SURGEONS IN IRELAND (IE) 2026-02-12 US claimed
EP-4565550-A1 FLUORINATION PROCESS Royal College of Surgeons in Ireland (IE) 2025-06-11 EP claimed
CN-118525019-A Process for preparing ledipasvir 科学与工业研究会(按照印度社会团体注册法案(1860年第21号法案)设立的注册机构) 2024-08-20 CN claimed
WO-2024110994-A1 A PROCESS FOR THE PREPARATION OF LEDIPASVIR COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH AN INDIAN REGISTERED BODY INCORPORATED UNDER THE REGN. OF SOC. ACT (ACT XXI OF 1860) (IN) 2024-05-30 WO claimed
WO-2024028729-A1 FLUORINATION PROCESS ROYAL COLLEGE OF SURGEONS IN IRELAND (IE) 2024-02-08 WO claimed
CN-112055712-A Processes and intermediates for preparing therapeutic compounds useful in the treatment of retroviral infections 吉利德科学公司 2020-12-08 CN claimed
US-9487470-B2 4-((substituted phenyl) difluoromethyl) phenoxy carboxylic acid derivative, and preparation method and uses thereof ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. (CN) 2016-11-08 US claimed
US-20150119458-A1 4-((SUBSTITUTED PHENYL) DIFLUOROMETHYL) PHENOXY CARBOXYLIC ACID DERIVATIVE, AND PREPARATION METHOD AND USES THEREOF ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. (CN) 2015-04-30 US claimed
EP-2842931-A1 4-((SUBSTITUTED PHENYL) DIFLUOROMETHYL) PHENOXY CARBOXYLIC ACID DERIVATIVE, AND PREPARATION METHOD AND USES THEREOF Zhejiang Hisun Pharmaceutical Co. Ltd. (CN) 2015-03-04 EP claimed
CN-116854630-B Methods and intermediates for preparing therapeutic compounds useful in the treatment of retroviral infections 吉利德科学公司 2026-05-19 CN disclosed
US-20260042715-A1 FLUORINATION PROCESS ROYAL COLLEGE OF SURGEONS IN IRELAND (IE) 2026-02-12 US disclosed
US-20260042715-A1 FLUORINATION PROCESS ROYAL COLLEGE OF SURGEONS IN IRELAND (IE) 2026-02-12 US disclosed
EP-4565550-A1 FLUORINATION PROCESS Royal College of Surgeons in Ireland (IE) 2025-06-11 EP disclosed
EP-4565550-A1 FLUORINATION PROCESS Royal College of Surgeons in Ireland (IE) 2025-06-11 EP disclosed
EP-2331515-A1 INSCETICIDAL COMPOUNDS Syngenta Participations AG (CH) 2011-06-15 EP disclosed
WO-2011033251-A1 HERBICIDAL ISOXAZOLINE DERIVATIVES SYNGENTA LIMITED (GB) 2011-03-24 WO disclosed
WO-2010130970-A1 HERBICIDAL COMPOUNDS SYNGENTA LIMITED (GB) 2010-11-18 WO disclosed
US-20100234605-A1 METHODS AND COMPOSITIONS FOR PRODUCING DIFLUOROMETHYLENE-AND TRIFLUOROMETHYL-CONTAINING COMPOUNDS IM&T RESEARCH, INC. (US) 2010-09-16 US disclosed
WO-2010020521-A1 INSCETICIDAL COMPOUNDS SYNGENTA PARTICIPATIONS AG (CH) 2010-02-25 WO disclosed
WO-2009076345-A1 METHODS AND COMPOSITIONS FOR PRODUCING DIFLUOROMETHYLENE-AND TRIFLUOROMETHYL-CONTAINING COMPOUNDS IM & T RESEARCH, INC. (US) 2009-06-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150119458-A1 4-((SUBSTITUTED PHENYL) DIFLUOROMETHYL) PHENOXY CARBOXYLIC ACID DERIVATIVE, AND PREPARATION METHOD AND USES THEREOF PPARA, PPARG, PPARD HDAC1 2334/4885HDAC6 1688/4885TTR 644/4885
US-20260042715-A1 FLUORINATION PROCESS XDH, VGF, GTF2F1 HDAC1 2274/4885HDAC6 720/4885TTR 3070/4885
US-20100234605-A1 METHODS AND COMPOSITIONS FOR PRODUCING DIFLUOROMETHYLENE-AND TRIFLUOROMETHYL-CONTAINING COMPOUNDS FDPS, PFAS, FBL HDAC1 3367/4885HDAC6 1040/4885TTR 2839/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.